NEW YORK (GenomeWeb) Cancer Genetics reported today that its fourth quarter revenues grew 32 percent year over year.

For the three months ended Dec. 31, 2016, the company reported revenues of $7.2 million up from $5.5 million in Q4 2015.

Registering provides access to this and other free content.

Already have an account? .

Read this article:
Cancer Genetics Q4 Revenues Up 32 Percent - GenomeWeb